HealthSouth Corporation (NYSE:HLS) issued an update on its FY17 earnings guidance on Monday morning. The company provided earnings per share guidance of $2.61-2.73 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.74. The company issued revenue guidance of $3.85-3.95 billion, compared to the consensus revenue estimate of $3.91 billion.
HealthSouth Corporation (NYSE:HLS) traded down 0.02% during trading on Monday, reaching $41.25. The company’s stock had a trading volume of 3,132,186 shares. HealthSouth Corporation has a 1-year low of $30.26 and a 1-year high of $43.38. The company has a market capitalization of $3.70 billion, a P/E ratio of 17.19 and a beta of 0.89. The company’s 50-day moving average is $41.53 and its 200-day moving average is $40.69.
HealthSouth Corporation (NYSE:HLS) last released its earnings results on Thursday, October 27th. The company reported $0.65 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.60 by $0.05. HealthSouth Corporation had a return on equity of 29.27% and a net margin of 6.31%. The firm had revenue of $926.80 million for the quarter, compared to the consensus estimate of $448.60 million. During the same period in the prior year, the business posted $0.52 earnings per share. The firm’s revenue for the quarter was up 19.0% compared to the same quarter last year. Equities analysts anticipate that HealthSouth Corporation will post $2.55 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, January 17th. Stockholders of record on Tuesday, January 3rd will be issued a $0.24 dividend. The ex-dividend date of this dividend is Thursday, December 29th. This represents a $0.96 dividend on an annualized basis and a dividend yield of 2.33%. HealthSouth Corporation’s dividend payout ratio (DPR) is 40.17%.
A number of equities analysts have recently commented on the company. Zacks Investment Research downgraded HealthSouth Corporation from a buy rating to a hold rating in a report on Wednesday, January 4th. Piper Jaffray Companies assumed coverage on HealthSouth Corporation in a report on Tuesday, January 3rd. They issued a neutral rating and a $45.00 price objective on the stock. RBC Capital Markets restated a buy rating and issued a $48.00 price objective on shares of HealthSouth Corporation in a report on Tuesday, January 3rd. Mizuho downgraded HealthSouth Corporation from a buy rating to a neutral rating in a report on Wednesday, November 9th. Finally, Royal Bank Of Canada increased their target price on HealthSouth Corporation from $46.00 to $48.00 and gave the company an outperform rating in a research note on Monday, October 31st. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have given a buy rating to the company’s stock. HealthSouth Corporation has an average rating of Buy and a consensus target price of $46.63.
In other news, CFO Douglas E. Coltharp bought 6,450 shares of the firm’s stock in a transaction dated Wednesday, November 9th. The stock was bought at an average price of $39.14 per share, for a total transaction of $252,453.00. Following the transaction, the chief financial officer now owns 104,637 shares in the company, valued at $4,095,492.18. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Also, COO Mark J. Tarr bought 6,371 shares of the firm’s stock in a transaction dated Wednesday, November 9th. The stock was purchased at an average price of $39.29 per share, with a total value of $250,316.59. Following the transaction, the chief operating officer now owns 238,890 shares in the company, valued at approximately $9,385,988.10. The disclosure for this purchase can be found here. Company insiders own 5.00% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “HealthSouth Corporation (HLS) Updates FY17 Earnings Guidance” was first posted by Community Financial News and is the propert of of Community Financial News. If you are reading this article on another site, it was stolen and reposted in violation of U.S. & international copyright & trademark legislation. The legal version of this article can be accessed at https://www.com-unik.info/2017/01/09/healthsouth-corporation-hls-updates-fy17-earnings-guidance.html.
Several hedge funds and other institutional investors have recently modified their holdings of the company. Piedmont Investment Advisors LLC bought a new stake in shares of HealthSouth Corporation during the third quarter valued at about $513,000. Verition Fund Management LLC bought a new stake in shares of HealthSouth Corporation during the third quarter valued at about $648,000. Panagora Asset Management Inc. bought a new stake in shares of HealthSouth Corporation during the third quarter valued at about $340,000. KCG Holdings Inc. increased its stake in shares of HealthSouth Corporation by 8.0% in the third quarter. KCG Holdings Inc. now owns 13,522 shares of the company’s stock valued at $549,000 after buying an additional 998 shares during the period. Finally, Profund Advisors LLC bought a new stake in shares of HealthSouth Corporation during the third quarter valued at about $228,000. Institutional investors own 97.10% of the company’s stock.
HealthSouth Corporation Company Profile
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in over 30 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company’s segments include inpatient rehabilitation, and home health and hospice.
What are top analysts saying about HealthSouth Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for HealthSouth Corporation and related companies.